Arizona Medical Cannabis News
U.S. cannabis sales through July were a mixed bag across the country, as consumers adjusted to historic inflation and shrinking disposable income, according to an analysis of state sales data by MJBizDaily.
Maridose has been licensed by the U.S Drug Enforcement Administration and Department of Justice for the bulk manufacture of cannabis to supply marijuana, MJ extracts (including isolated chemical constituents) and THC to researchers.
The failure of a key marijuana bill in Arizona’s Legislature has triggered an angry round of the blame game by social equity advocates, who charge that more established companies torpedoed the bill because they want to keep the state’s cannabis market to themselves.
Cannabis growers are confronting the same issue that threatens to upend the wine industry and other agricultural-based businesses – shifting weather patterns and climate change.
Those shifts are forcing cannabis growers to rethink how to cultivate their plants.
U.S. and Canadian marijuana retailers are discounting their products more and more, forgoing billions of dollars in revenue since the launch of adult-use markets in recent years.
Most of the largest U.S. marijuana multistate operators experienced revenue declines in the first quarter of 2022 versus the previous three months, reflecting seasonal factors, declining cannabis prices and inflationary pressures that could be curbing consumer spending.
Item 9 Labs Corp., an Arizona-based company that invests in marijuana-related businesses, signed an agreement to acquire Wild Card Cannabis, which includes Sessions Cannabis, one of the largest franchise MJ companies in Canada.
